Description: This book reviews some of the changes occurring in addiction medicine regarding the area of craving/replacement pharmacotherapy and its integration into current psychosocial treatments.
Purpose: The purpose is to review recent information regarding the development of newer medications used in addictive disorders and how these should be optimally administered in addiction treatment programs.
Audience: The book is written for the average clinician working in the addiction field. It is easily understood by individuals of all educational and clinical levels. The editor and contributors are experts in this field. The editor is extensively published in this area and adds a few of his own unique insights in a number of the chapters.
Features: The book falls short of accomplishing what the title promises. It consists of a number of review articles that cover newer medications used in addictions, a chapter that reviews over the biological/genetic vulnerability to addictions, and two chapters devoted to the treatment of dual diagnosis patients. There are two chapters that are noteworthy. The first is a review of the European approach to integrating addiction pharmacotherapy with psychosocial treatments. The second is a brief review of all pharmacological agents under investigation for the treatment of addictive disorders. The text has adequate illustrations and charts. The references are relevant and up to date.
Assessment: Overall, this text is limited and very general. It is not original in its topic matter and most of this information can be found in a number of other sources.